These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6308886)

  • 21. Studies on soluble complement fixing antigen of Japanese encephalitis virus.
    Rai J; Ghosh SN
    Indian J Med Res; 1976 Jul; 64(7):981-91. PubMed ID: 992838
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of the occurrence of antibodies to human cytomegalovirus as demonstrated by complement fixation, enzyme-linked-immunosorbent assay and indirect immunofluorescence.
    Landini MP; Re MC; Coppolecchia P
    Boll Ist Sieroter Milan; 1982; 61(4):320-3. PubMed ID: 6100235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Complement fixation test act in the diagnosis of mucosal disease-virus diarrhea in cattle].
    Petkova K; Ognianov D; Tsvetkov P; Bachiĭski L
    Vet Med Nauki; 1980; 17(9-10):43-7. PubMed ID: 6266127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of supraoptimal temperature on the multiplication of different cytomegalovirus strains.
    Gönczöl E; Váczi L; Boldogh I
    Acta Microbiol Acad Sci Hung; 1975; 22(1):19-26. PubMed ID: 163057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antisera to human cytomegaloviruses prepared in the guinea pig: specific immunofluorescence and complement fixation tests.
    Huang YT; Huang ES; Pagano JS
    J Immunol; 1974 Feb; 112(2):528-32. PubMed ID: 4360544
    [No Abstract]   [Full Text] [Related]  

  • 26. Complement fixing antigens in rabies. VI. Correlation of complement fixing and neutralizing antibodies.
    Rai Chowdhuri AN; Bhardwaj M; Sivaraman CA
    J Commun Dis; 1980 Dec; 12(4):197-200. PubMed ID: 7320482
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytomegalovirus antibodies in renal transplant recipients.
    Jankowski M; Gut W; Nawrocka E; Gradowska L; Roncewicz Z; Rowińska D
    Acta Microbiol Pol; 1982; 31(3-4):279-85. PubMed ID: 6189377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrastructural and biological properties of a cytomegalovirus rescued from a human paraganglioma.
    Heine U; Kondratick J; Ablashi DV; Armstrong GR; Dalton AJ
    Cancer Res; 1971 May; 31(5):542-9. PubMed ID: 4325836
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diagnostic tests: Cytomegalovirus].
    Fujieda M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():297-9. PubMed ID: 16111255
    [No Abstract]   [Full Text] [Related]  

  • 30. An evaluation under code of new techniques for the detection of cytomegalovirus antibodies: sensitivity of assays and importance of immune complexes.
    Cheung KS; Roche JK; Capel WD; Lang DJ
    J Clin Lab Immunol; 1981 Nov; 6(3):269-74. PubMed ID: 6279849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement-fixing antibodies against cytomegalovirus in different parts of the world.
    Krech U
    Bull World Health Organ; 1973; 49(1):103-6. PubMed ID: 4363395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Production, purification and evaluation of human cytomegalovirus 66 kD structural antigen for antibody detection by ELISA].
    Gireaudot P; Dewilde A; Lobert PE; Bocket-Mouton L; Wattre P
    Pathol Biol (Paris); 1989 Dec; 37(10):1141-4. PubMed ID: 2558339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of antibodies to human cytomegalovirus in patients with different forms of cancer and in other categories of subjects.
    Stoian M; Hozoc M; Iosipenco M; Bolocan J; Nastac E
    Virologie; 1982; 33(2):153-61. PubMed ID: 6293166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Productive and abortive replication of human cytomegalovirus at different environmental pH values.
    Zerbini M; Musiani M; Carpi C; Falcieri E
    Arch Virol; 1982; 72(1-2):127-31. PubMed ID: 6285862
    [No Abstract]   [Full Text] [Related]  

  • 35. [Localization by immunoperoxidase of cytomegalovirus antigens in human fibroblast cell cultures. Light and electron microscopy].
    Kurstak E; Belloncik S; Onji PA; Montplaisir S; Martineau B
    Arch Gesamte Virusforsch; 1972; 38(1):67-76. PubMed ID: 4341303
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunological destruction in vitro of cytomegalovirus infected cells.
    Diosi P; David C
    Br Med J; 1973 May; 2(5862):364-5. PubMed ID: 4350113
    [No Abstract]   [Full Text] [Related]  

  • 37. [Development of a method for preparing adeno-associated virus type 4 antigen].
    Dreĭzin RS; Zolotarskaia EE; Dukhovnaia EM
    Vopr Virusol; 1976; (1):111-6. PubMed ID: 1258451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Optimal conditions for production of complement-fixing antigens of para-influenza viruses].
    Mel'nichenko EI; Zakstel'skaia LIa; Iakhno MA; Selivanov IaM; Balnokina SI
    Vopr Virusol; 1974; (1):95-100. PubMed ID: 4374819
    [No Abstract]   [Full Text] [Related]  

  • 39. Interactions of human cytomegalovirus with human fibroblasts.
    Vonka V; Benyesh-Melnick M
    J Bacteriol; 1966 Jan; 91(1):213-20. PubMed ID: 4285532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability and storage of rubella complement fixing antigen.
    Schell K; Wong KT
    Nature; 1966 Nov; 212(5062):621-2. PubMed ID: 4961646
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.